Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Real‐life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA
Sven Seys, Shana De Bont, Wytske J. Fokkens, et al.
Allergy (2020) Vol. 75, Iss. 11, pp. 2867-2878
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

International consensus statement on allergy and rhinology: rhinosinusitis 2021
Richard R. Orlandi, Todd T. Kingdom, Timothy L. Smith, et al.
International Forum of Allergy & Rhinology (2020) Vol. 11, Iss. 3, pp. 213-739
Open Access | Times Cited: 621
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
Joseph K. Han, Claus Bachert, Wytske J. Fokkens, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 10, pp. 1141-1153
Closed Access | Times Cited: 408
Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era
Joaquim Mullol, Antoine Azar, Kathleen M. Buchheit, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1434-1453.e9
Open Access | Times Cited: 91
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposis
Philippe Gevaert, Jarno De Craemer, Claus Bachert, et al.
Allergy (2023) Vol. 78, Iss. 4, pp. 912-922
Open Access | Times Cited: 42
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
Joaquim Mullol, Claus Bachert, Nikhil Amin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 4, pp. 1086-1095.e5
Open Access | Times Cited: 74
Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis
Shiru Cai, Shenglong Xu, Hongfei Lou, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 7, pp. 1876-1886.e7
Closed Access | Times Cited: 60
Real-Life Effectiveness of Mepolizumab in Refractory Chronic Rhinosinusitis with Nasal Polyps
María Sandra Domínguez-Sosa, María Soledad Cabrera-Ramírez, Miriam del Carmen Marrero-Ramos, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 485-485
Open Access | Times Cited: 32
Highlights in the advances of chronic rhinosinusitis
Xinni Xu, Sietze Reitsma, De Yun Wang, et al.
Allergy (2021) Vol. 76, Iss. 11, pp. 3349-3358
Closed Access | Times Cited: 44
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In‐depth sinus surgery analysis
Wytske J. Fokkens, Joaquim Mullol, David W. Kennedy, et al.
Allergy (2022) Vol. 78, Iss. 3, pp. 812-821
Open Access | Times Cited: 31
Evaluating enrollment and outcome criteria in trials of biologics for chronic rhinosinusitis with nasal polyps
Larry Borish, Noah Cohen, Geoffrey Chupp, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 129, Iss. 2, pp. 160-168
Open Access | Times Cited: 23
Evaluating treatment response to mepolizumab in patients with severe CRSwNP
C. Hopkins, JK Han, Valerie Lund, et al.
Rhinology Journal (2023)
Open Access | Times Cited: 15
Air pollution, genetic factors, and chronic rhinosinusitis: A prospective study in the UK Biobank
Qinfeng Zhou, Junxiong Ma, Shyam Biswal, et al.
The Science of The Total Environment (2024) Vol. 940, pp. 173526-173526
Closed Access | Times Cited: 5
Therapies for Olfactory Dysfunction — an Update
Aria Jafari, Eric H. Holbrook
Current Allergy and Asthma Reports (2022) Vol. 22, Iss. 3, pp. 21-28
Open Access | Times Cited: 22
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Bernardo Sousa‐Pinto, Aram Antó, Markus Berger, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 21
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study
Wytske J. Fokkens, Andrew Trigg, Stella E. Lee, et al.
Journal of Patient-Reported Outcomes (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 11
Real-world effectiveness of dupilumab in a European cohort of CRSwNP (CHRINOSOR)
Sven Seys, Sven Schneider, Joost de Kinderen, et al.
Journal of Allergy and Clinical Immunology (2024)
Closed Access | Times Cited: 4
Olfaction and drug delivery to the human olfactory airspace: current challenges and recent advances
Dennis O. Frank‐Ito
Expert Opinion on Drug Delivery (2025)
Closed Access
The Impact and Burden of Chronic Rhinosinusitis with Nasal Polyps on Patients and Their Family Caregivers: A Nationally Representative Survey
Luca Malvezzi, Veronica Seccia, Antonio Moffa, et al.
Healthcare (2025) Vol. 13, Iss. 4, pp. 430-430
Open Access
Evaluating nebulisation and nasal irrigation efficiency in post-operative chronic rhinosinusitis patients through computational fluid dynamics simulation
O. Pourmehran, Alkis J. Psaltis, Sarah Vreugde, et al.
Computer Methods and Programs in Biomedicine (2025) Vol. 264, pp. 108697-108697
Open Access
Evaluation of LYR‐220 Mometasone Sinonasal Implants in Patients With Chronic Rhinosinusitis and Prior Ethmoid Surgery: Results From the Randomized, Blinded, Controlled BEACON Phase 2 Study
Brent A. Senior, Randall A. Ow, M. Scott Major, et al.
International Forum of Allergy & Rhinology (2025)
Closed Access
Association between outdoor air pollution and chronic rhinosinusitis patient reported outcomes
S. Peeters, C. Wang, Esmée M. Bijnens, et al.
Environmental Health (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Automatic market research of mobile health apps for the self‐management of allergic rhinitis
Aram Antó, Bernardo Sousa‐Pinto, Heather J. Zar, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 10, pp. 1195-1207
Open Access | Times Cited: 16
Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial
Jorge Máspero, Asif Khan, Carl Philpott, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 323-332
Open Access | Times Cited: 10
The “real life” efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP
Nicholas J. Campion, Jonas Brugger, Aldine Tu, et al.
Journal of Otolaryngology - Head and Neck Surgery (2023) Vol. 52, Iss. 1
Open Access | Times Cited: 9
Impact of Dupilumab on Sinonasal Symptoms and Outcomes in Severe Chronic Rhinosinusitis With Nasal Polyps
Claire Hopkins, Joaquim Mullol, Asif Khan, et al.
Otolaryngology (2023) Vol. 170, Iss. 4, pp. 1173-1182
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top